DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/5b54vr\/us_personalized<\/a>) has announced the addition of the \"US Personalized Cancer Genome Sequencing Market\" report to their offering. <\/p>\n The US personalized cancer Genome Sequencing market is primarily classified into Targeted Genome Sequencing and Whole-Genome Sequencing. Our report entitled US Personalized Cancer Genome Sequencing Market takes into account the Whole-Genome Sequencing services, which is one of the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. <\/p>\n In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome Sequencing market, our report has effectively studied the current and future status of cancer in the US as well as its States. In view of the fact that cancer affects some specific age groups in a significant manner, we have also investigated the age-wise statistics of the disease. To get proper insight into the market, an in-depth analysis into the high-income group population is provided so that players can have a clear picture about their potential customer base and the market to be tapped. <\/p>\n The WGS industry has evolved in US in the recent times, and the level and seriousness of implementation has seen drastic changes. An in-depth study of the regulatory environment governing the US personalized cancer Whole-Genome Sequencing market has also been provided. It has been found that regulations related to personalized cancer sequencing are primarily governed with the accreditation of the laboratories performing the sequencing services and analysis, and also the usage of FDA approved tests for conducting these tests. Further, we have also discussed the various constraints faced by the industry players with suitable suggestions to overcome them. <\/p>\n The report analyzes the competitive landscape in the market by properly analyzing the business, services and activities of the companies. It also provides the competitive benchmarking, taking into account the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for the clients who want to get an in-depth understanding of the market. <\/p>\n Key Topics Covered: <\/p>\n 1. Analyst View <\/p>\n 2. Research Methodology <\/p>\n 3. Cancer Statistics by Demographics <\/p>\n <\/p>\n See more here: DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/5b54vr\/us_personalized<\/a>) has announced the addition of the \"US Personalized Cancer Genome Sequencing Market\" report to their offering. Continue reading
\nResearch and Markets: US Personalized Cancer Genome Sequencing Market Report: 2013 Edition<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"